Exelixis
EXEL
#1325
Rank
S$21.73 B
Marketcap
S$89.07
Share price
1.25%
Change (1 day)
65.29%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

EPS for Exelixis (EXEL)

EPS in 2023 (TTM): S$0.38

According to Exelixis's latest financial reports the company's current EPS (TTM) is S$4.43. In 2022 the company made an earnings per share (EPS) of S$0.73 a decrease over its 2021 EPS that were of S$0.95.

EPS history for Exelixis from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$0.38-47.73%
2022S$0.73-22.97%
2021S$0.95100%
2020S$0.47-65.09%
2019S$1.36-53.91%
2018S$2.94333.96%
2017S$0.68-260.61%
2016S-$0.42-58.75%
2015S-$1.02-42.45%
2014S-$1.785.3%
2013S-$1.6943.48%
2012S-$1.18-264.29%
2011S$0.72-165.88%
2010S-$1.09-32.54%
2009S-$1.61-17.65%
2008S-$1.9675.86%
2007S-$1.11-25.64%
2006S-$1.508.33%
2005S-$1.38-42.86%
2004S-$2.4230.34%
2003S-$1.86-5.23%
2002S-$1.96-0.65%
2001S-$1.97-51.88%
2000S-$4.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.56 93.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$0.97-78.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$20.77 368.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.44-45.00%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$1.27-71.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.79 30.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$3.68-16.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
S-$18.21-510.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S-$1.08-124.28%๐Ÿ‡บ๐Ÿ‡ธ USA